EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Transplantation and the HIV Latent Viral Reservoir

J Natalie Howard, Melissa L Smith, Ashwin Balagopal iD, Christine M Durand iD, Andrew D Redd, Aaron A R Tobian iD

The Journal of Infectious Diseases · 28.10.2026

DOI: 10.1093/infdis/jiag526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 28.10.2026. Verfasst von J Natalie Howard und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health, Intramural Research Program of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite antiretroviral therapy, the latent viral reservoir (LVR) remains the primary barrier to human immunodeficiency virus (HIV) cure. Both hematopoietic and solid organ transplantation (SOT) have provided optimism for cure and significant insights into LVR composition and maintenance. There have been 13 reported cases of acquired cure, all in individuals receiving allogeneic hematopoietic stem cell transplants (allo-HSCT). While infeasible for most, these cases have provided important lessons about the LVR. Impacts of SOT on the LVR have also been investigated. In kidney transplantation where recipients were T-cell depleted, the LVR initially decreased before rebounding and eventually surpassed the LVR of recipients without T-cell depletion. Despite transplanting a large lymphoid organ, studies have found no impact of HIV+ liver transplants on LVR size in recipients. Given that SOTs are more accessible globally than allo-HSCTs, lessons learned about the LVR from these studies can inform potential cure avenues that may be more feasible and attainable.

Schlagwörter

Stichwörter der Autor:innen

HIV/AIDSLatent viral reservoirTransplantation

Autor:innen und Institutionen

  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY, USA.
  • Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

ORCID-Profile: Ashwin Balagopal, Christine M Durand, Aaron A R Tobian

Förderung

  • National Institutes of Health
  • Intramural Research Program of the National Institutes of Health

Zitieren

APA

Howard, J. N., Smith, M. L., Balagopal, A., Durand, C. M., Redd, A. D., & Tobian, A. A. R. (2026). Transplantation and the HIV Latent Viral Reservoir. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag526

Vancouver

Howard JN, Smith ML, Balagopal A, Durand CM, Redd AD, Tobian AAR. Transplantation and the HIV Latent Viral Reservoir. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag526

BibTeX
@article{Howard2026,
  author = {Howard, J Natalie and Smith, Melissa L and Balagopal, Ashwin and Durand, Christine M and Redd, Andrew D and Tobian, Aaron A R},
  title = {Transplantation and the HIV Latent Viral Reservoir},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag526}
}
Kostenlos starten →